Galit Zuckerman Stark, Founder & CEO, MedaSense Biometrics

Galit Zuckerman Stark, CEO and cofounder of Medasense. Medasense is NOL technology, enables clinician to personalize pain management, optimize treatment and avoid overmedication. All this in it with a noninvasive sensor platform and AI technology.

 01:14 What brought you to the medical field and to becoming the CEO of a breakthrough product in what is actually a very difficult market to operate in?

03:18 How did you get to pain as a field of interest?

05:05 Why is there a need for an objective measurement of pain?

09:05 Can you go back to 10-11 years ago and share what you were thinking your product process was going to be? And then go to, where you are now and what your product actually is?

13:40 What do you think are the main things that have changed in the “Pain industry” and allowed you to sell products and raise significant amounts of capital from investors?

16:46 Can you explain a little bit about how Medasense’s technology works? 

20:03 How is Medasense’s pain score personalized?

20:59 Are you only addressing the pain component of surgery or are you helping the anesthesiologist manage the types of medications administered during surgery?

22:54 How and why did you make the decision to work with a large multinational company such as Medtronic for distribution?

26:08 it's quite unusual for an Israeli company to start with Europe. Why did you decide to begin your sales in Europe? 

28:50 How do you make sure you don’t lose touch with the market when you sell through distributors? 

34:10 Who helped you during the transition from a product company to a commercialization

36:59 What's next for Medasense?

41:05 How does your product work with patients who can communicate? How can you reconcile the gap between your measurement and what the patient is saying? 

43:20 Do you think you have different challenges because you're a female CEO in this space? And if so, you know, do you have any tips for other female CEOs?